These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15003426)

  • 21. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Am J Psychiatry; 1997 Oct; 154(10):1430-5. PubMed ID: 9326827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder.
    Coccaro EF; Kavoussi RJ; Hauger RL
    Int Clin Psychopharmacol; 1995 Sep; 10(3):177-9. PubMed ID: 8675971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT; Porter RJ; Joyce PR
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fenfluramine challenge in unipolar depression with and without anger attacks.
    Fava M; Vuolo RD; Wright EC; Nierenberg AA; Alpert JE; Rosenbaum JF
    Psychiatry Res; 2000 Apr; 94(1):9-18. PubMed ID: 10788673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychobiological differences between the aggression and psychoticism dimension.
    Netter P; Hennig J; Rohrmann S
    Pharmacopsychiatry; 1999 Jan; 32(1):5-12. PubMed ID: 10071177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease.
    Lanctôt KL; Herrmann N; Eryavec G; van Reekum R; Reed K; Naranjo CA
    Neuropsychopharmacology; 2002 Oct; 27(4):646-54. PubMed ID: 12377401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal responses to dl-fenfluramine challenge are not blunted in seasonal affective disorder.
    Yatham LN; Michalon M
    Psychoneuroendocrinology; 1995; 20(4):433-8. PubMed ID: 8532826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fenfluramine challenge, self-injurious behavior, and aggression in rhesus monkeys.
    Tiefenbacher S; Davenport MD; Novak MA; Pouliot AL; Meyer JS
    Physiol Behav; 2003 Nov; 80(2-3):327-31. PubMed ID: 14637232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects.
    Coccaro EF; Kavoussi RJ; Hauger RL; Cooper TB; Ferris CF
    Arch Gen Psychiatry; 1998 Aug; 55(8):708-14. PubMed ID: 9707381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.
    Flory JD; Manuck SB; Perel JM; Muldoon MF
    Psychopharmacology (Berl); 2004 Jul; 174(3):376-80. PubMed ID: 14997271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample.
    Manuck SB; Flory JD; McCaffery JM; Matthews KA; Mann JJ; Muldoon MF
    Neuropsychopharmacology; 1998 Oct; 19(4):287-99. PubMed ID: 9718592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
    Young AH; Rue J; Odontiadis J; Cowen PJ
    Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.
    Oquendo MA; Placidi GP; Malone KM; Campbell C; Keilp J; Brodsky B; Kegeles LS; Cooper TB; Parsey RV; van Heertum RL; Mann JJ
    Arch Gen Psychiatry; 2003 Jan; 60(1):14-22. PubMed ID: 12511168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system serotonergic responsivity and aggressive disposition in men.
    Manuck SB; Flory JD; Muldoon MF; Ferrell RE
    Physiol Behav; 2002 Dec; 77(4-5):705-9. PubMed ID: 12527023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior.
    Coccaro EF; Harvey PD; Kupsaw-Lawrence E; Herbert JL; Bernstein DP
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):S44-51. PubMed ID: 1821222
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship of temperament and behaviour measures to the prolactin response to fenfluramine in depressed men.
    Mulder RT; Joyce PR
    Psychiatry Res; 2002 Apr; 109(3):221-8. PubMed ID: 11959359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retest reliability of prolactin response to dl-fenfluramine challenge in adults.
    Flory JD; Manuck SB; Muldoon MF
    Neuropsychopharmacology; 2002 Feb; 26(2):269-72. PubMed ID: 11790522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.